Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astonea LabsBOM:544409 12 Days Inventory is 54.91 as of Mar. 2026, which is 56% below its 10-year median of 124.53. GuruFocus rates BOM:544409 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Astonea Labs ranks worse than 68.8% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Astonea Labs's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹299.8 Mil. Astonea Labs's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹498.1 Mil.
Hence, Astonea Labs's Days Inventory for the
three
months ended in Mar. 2026 was 54.91.
The historical rank and industry rank for Astonea Labs's Days Inventory or its related term are showing as below:
BOM:544409'
s Days Inventory Range Over the Past 10 Years
Min: 79.11 Med: 124.53 Max: 218.12
Current: 218.12
During the past 5 years, Astonea Labs's highest Days Inventory was 218.12. The lowest was 79.11. And the median was 124.53.
BOM:544409's Days Inventory is ranked worse than 68.8% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:544409: 218.12
Astonea Labs's Days Inventory
increased
from Mar. 2024 (0.00) to Mar. 2026 (54.91).
It might indicate that Astonea Labs's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Astonea Labs's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Astonea Labs's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.37.
Astonea Labs (BOM:544409) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Astonea Labs's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Astonea Labs's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Astonea Labs Days Inventory Related Terms
Astonea Labs Days Inventory Historical Data
* Premium members only.
The historical data trend for Astonea Labs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Astonea Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astonea Labs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Astonea Labs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Astonea Labs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astonea Labs (BOM:544409) has a Days Inventory of 54.91 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Astonea Labs and its competitors. This is 56% below median its historical median of 124.53. Over the past decade, Astonea Labs' Days Inventory has ranged from 79.11 to 218.12. According to the industry distribution chart, Astonea Labs ranks #635 out of 923 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is Astonea Labs' Days Inventory too high?
Astonea Labs' current Days Inventory of 54.91 is 56% below median its 10-year median of 124.53. Over the past 10 years, this metric has ranged from a low of 79.11 to a high of 218.12. The Drug Manufacturers industry median Days Inventory is 164.87. Astonea Labs' value of 54.91 is 66.7% below this industry median. Based on the distribution chart, Astonea Labs ranks #635 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Astonea Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Astonea Labs' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Astonea Labs ranks #635 out of 923 companies for Days Inventory. This places Astonea Labs in the lower half of its industry. The industry median Days Inventory is 164.87. Astonea Labs' value of 54.91 is 66.7% below this benchmark. Historically, Astonea Labs' own Days Inventory has ranged from 79.11 to 218.12 over the past decade. While the company's 10-year median is 124.53 vs. the industry median of 164.87, Astonea Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astonea Labs's current Days Inventory of 54.91 is 66.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Astonea Labs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astonea Labs's current Days Inventory is 54.91, which is 56% below median its own 10-year median of 124.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astonea Labs stock overvalued right now?
Astonea Labs (BOM:544409) has a current Days Inventory of 54.91. The current Days Inventory is 54.91, which is 56% below median its 10-year median of 124.53 and 66.7% below the Drug Manufacturers industry median of 164.87. Astonea Labs' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Astonea Labs (BOM:544409), the current Days Inventory is 54.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Astonea Labs Ltd is an India-based pharmaceutical and cosmetics company engaged in the manufacturing and development of healthcare and personal care products. The Company operates in the pharmaceuticals and cosmetics & personal care space, offering products that include generic medicines, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as skincare, haircare, anti-aging, ethical, and organic cosmetic products, supported by in-house research and development and contract manufacturing services. Its business activities are organized across key segments comprising Pharmaceuticals, Cosmetics & Personal Care, R&D & Innovation, and Contract Manufacturing (CDMO).
12GF Score
Get the complete analysis for BOM:544409
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544409 has been successfully added to your 
